Yoshida, Naoya
Eto, Kojiro
Horinouchi, Tomo
Harada, Kazuto
Sawayama, Hiroshi
Ogawa, Katsuhiro
Nagai, Yohei
Iwatsuki, Masaaki
Iwagami, Shiro
Ishimoto, Takatsugu
Baba, Yoshifumi
Miyamoto, Yuji
Baba, Hideo
Article History
Received: 5 May 2022
Accepted: 31 July 2022
First Online: 27 August 2022
Disclosure
: Naoya Yoshida and Takatsugu Ishimoto are members of the department supported by Chugai Pharmaceutical Co., Ltd and Yakuruto Honsya Co., Ltd, but have no conflicts of interest regarding this research. Yoshifumi Baba is a member of the department supported by Taiho Pharmaceutical Co., Ltd, but has no conflicts of interest regarding this research. Hideo Baba, Kojiro Eto, Tomo Horinouchi, Kazuto Harada, Hiroshi Sawayama, Katsuhiro Ogawa, Yohei Nagai, Masaaki Iwatsuki, Shiro Iwagami, and Yuji Miyamoto have no conflicts of interest or financial ties to disclose.